M. Qazilbash

871 total citations
22 papers, 602 citations indexed

About

M. Qazilbash is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, M. Qazilbash has authored 22 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in M. Qazilbash's work include Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). M. Qazilbash is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). M. Qazilbash collaborates with scholars based in United States and Argentina. M. Qazilbash's co-authors include Sergio Giralt, Chitra Hosing, Richard E. Champlin, Paolo Anderlini, Issa F. Khouri, Daniel R. Couriel, Börje S. Andersson, Rima M. Saliba, Marcos de Lima and Elizabeth J. Shpall and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

M. Qazilbash

22 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Qazilbash United States	11	374	257	180	154	97	22	602
Mahasweta Gooptu United States	16	432 1.2×	201 0.8×	192 1.1×	123 0.8×	51 0.5×	66	683
J. L. Harousseau France	14	436 1.2×	293 1.1×	133 0.7×	199 1.3×	187 1.9×	35	812
Annette M. May Germany	14	258 0.7×	131 0.5×	125 0.7×	197 1.3×	52 0.5×	35	559
Ilana Zalcberg Brazil	14	297 0.8×	231 0.9×	132 0.7×	246 1.6×	196 2.0×	53	739
Sharon Tindle United States	9	639 1.7×	312 1.2×	144 0.8×	153 1.0×	48 0.5×	19	742
Mitsutoshi Kurosawa Japan	13	241 0.6×	209 0.8×	108 0.6×	119 0.8×	140 1.4×	49	610
D Samson United Kingdom	14	549 1.5×	196 0.8×	169 0.9×	213 1.4×	43 0.4×	23	684
VM Santana United States	9	240 0.6×	310 1.2×	101 0.6×	185 1.2×	119 1.2×	11	674
Roberto Sorasio Italy	14	542 1.4×	291 1.1×	108 0.6×	286 1.9×	210 2.2×	33	853
Karthik A. Ganapathi United States	13	145 0.4×	203 0.8×	223 1.2×	171 1.1×	223 2.3×	22	616

Countries citing papers authored by M. Qazilbash

Since Specialization

Citations

This map shows the geographic impact of M. Qazilbash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Qazilbash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Qazilbash more than expected).

Fields of papers citing papers by M. Qazilbash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Qazilbash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Qazilbash. The network helps show where M. Qazilbash may publish in the future.

Co-authorship network of co-authors of M. Qazilbash

This figure shows the co-authorship network connecting the top 25 collaborators of M. Qazilbash. A scholar is included among the top collaborators of M. Qazilbash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Qazilbash. M. Qazilbash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qazilbash, M., Qaiser Bashir, Denái R. Milton, et al.. (2019). PS1541 OUTCOMES OF AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR BPDCN. HemaSphere. 3(S1). 711–712. 1 indexed citations

Olson, Amanda, Robert L. Coleman, M. Qazilbash, et al.. (2018). A phase I trial of mesenchymal stem cells transfected with a plasmid secreting interferon beta in advanced ovarian cancer. Cytotherapy. 20(5). S11–S12. 2 indexed citations

Qazilbash, M., Eric Wieder, Peter F. Thall, et al.. (2016). PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies. Leukemia. 31(3). 697–704. 72 indexed citations

Kongtim, Piyanuch, M. Qazilbash, Jatin J. Shah, et al.. (2015). High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis. Bone Marrow Transplantation. 50(5). 668–672. 6 indexed citations

Merriman, Kelly W., Heather Lin, M. Wang, et al.. (2014). The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. British Journal of Cancer. 111(3). 628–636. 61 indexed citations

Yılmaz, Musa, Roy F. Chemaly, Xiaoyan Han, et al.. (2013). Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplantation. 48(9). 1218–1223. 28 indexed citations

Foglietta, Myriam, Sattva S. Neelapu, Larry W. Kwak, et al.. (2012). Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. Bone Marrow Transplantation. 48(2). 269–277. 9 indexed citations

Kebriaei, Partow, Timothy Madden, X. Wang, et al.. (2012). Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL. Bone Marrow Transplantation. 48(1). 26–31. 10 indexed citations

Nieto, Yago, Roy B. Jones, P. Liu, et al.. (2012). Comparison of Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) with Beam and Busulfan/Melphalan (Bu/Mel) in Concurrent Cohorts of Refractory Hodgkin'S Lymphoma (HL) Patients Receiving an Autologous Stem-Cell Transplant. Biology of Blood and Marrow Transplantation. 18(2). S206–S207. 1 indexed citations

10.

Nieto, Yago, Roy B. Jones, Uday Popat, et al.. (2012). Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) Is a New High-Dose Chemotherapy (HDC) Regimen with High Activity in Refractory or Poor-Risk Relapsed Non-Hodgkin'S Lymphoma (NHL) Patients Receiving an Autologous Stem-Cell Transplant (ASCT). Biology of Blood and Marrow Transplantation. 18(2). S206–S206. 1 indexed citations

11.

Beitinjaneh, Amer, Rima M. Saliba, Grace‐Julia Okoroji, et al.. (2011). Autologous stem cell transplantation (ASCT) as upfront or salvage therapy for noncutaneous T-cell lymphoma (TCL): The University of Texas M. D. Anderson Cancer Center (MDACC) experience.. Journal of Clinical Oncology. 29(15_suppl). 6565–6565. 5 indexed citations

12.

Popat, Uday, Marcos J. de Lima, Rima M. Saliba, et al.. (2011). Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR. Bone Marrow Transplantation. 47(2). 212–216. 18 indexed citations

13.

Khouri, Issa F., Rima M. Saliba, M Körbling, et al.. (2011). Bendamustine in combination with fludarabine and rituximab: A novel nonmyeloablative conditioning for allogeneic stem cell transplantation (AST) in patients with lymphoid malignancies.. Journal of Clinical Oncology. 29(15_suppl). e18511–e18511. 1 indexed citations

14.

Kazmi, Syed Mohammad Ali, Rima M. Saliba, Michèle L. Donato, et al.. (2010). Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma. Bone Marrow Transplantation. 46(4). 510–515. 20 indexed citations

15.

Wang, M, Kay Delasalle, Lei Feng, et al.. (2009). CR represents an early index of potential long survival in multiple myeloma. Bone Marrow Transplantation. 45(3). 498–504. 39 indexed citations

16.

Popat, Uday, Rima M. Saliba, Grace‐Julia Okoroji, et al.. (2008). 96: Incidence and Factors Influencing Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD). Biology of Blood and Marrow Transplantation. 14(2). 37–38. 1 indexed citations

17.

Anderlini, Paolo, Sandra Acholonu, Sergio Giralt, et al.. (2008). Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience. Haematologica. 93(2). 257–264. 94 indexed citations

18.

Qazilbash, M., Rima M. Saliba, Chitra Hosing, et al.. (2007). Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma. Bone Marrow Transplantation. 39(5). 279–283. 28 indexed citations

19.

Kurian, Sobha, M. Qazilbash, Joseph W. Fay, et al.. (2006). Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplatation in Metastatic Breast Cancer Results in Survival Benefit. The Breast Journal. 12(6). 531–535. 11 indexed citations

20.

Lima, M., Sergio Giralt, M. Qazilbash, et al.. (2005). Results of a Phase I/II Study of Gemtuzumab Ozogamicin Added to Fludarabine (F), Melphalan (M) and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed Myeloid Leukemias.. Blood. 106(11). 841–841. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact